These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8306923)

  • 21. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of phospholipid liposomes in the treatment of neuropsychological disorders associated with the menopause: a double-blind, randomised, placebo-controlled study.
    Rachev E; Nalbansky B; Kolarov G; Agrosì M
    Curr Med Res Opin; 2001; 17(2):105-10. PubMed ID: 11759177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
    Daléry J; Aubin V
    Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of anxiety with bromazepam in clinical practice (author's transl)].
    Bornstein S; Benoudich H; Kaufman E; Konqui M; Pigeon P
    Nouv Presse Med; 1982 May; 11(22):1731-4. PubMed ID: 6124945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bromazepam in anxiety. Clinical evaluation (author's transl)].
    Perret J; Zagala A; Gaio JM; Hommel M; Meaulle F; Pellat J; Pollak P
    Nouv Presse Med; 1982 May; 11(22):1722-4. PubMed ID: 6124942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A; Korotzer A; Gommoll C; Li D
    Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
    Volz HP; Murck H; Kasper S; Möller HJ
    Psychopharmacology (Berl); 2002 Nov; 164(3):294-300. PubMed ID: 12424553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
    Russell JM; Weisberg R; Fava M; Hartford JT; Erickson JS; D'Souza DN
    Depress Anxiety; 2008; 25(7):E1-11. PubMed ID: 17587217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation.
    Weir JH
    J Clin Psychiatry; 1978 Dec; 39(12):841-7. PubMed ID: 721788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical trial of bromazepam in hospital psychiatry (author's transl)].
    Kress JJ; Maheo M; Cledes A; Chastaing A; Conan P
    Nouv Presse Med; 1982 May; 11(22):1735-7. PubMed ID: 6124946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compared efficacy of prazepam and clomipramine in major depression with anxiety: a multicenter controlled study.
    Lemoine P; Boulenger JP; Caillard V; Tanne N; Bonnet D
    Pharmacopsychiatry; 1991 Sep; 24(5):175-9. PubMed ID: 1775523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The action of bromazepam on anxiety (author's transl)].
    Amphoux G; Agussol P; Girard J
    Nouv Presse Med; 1982 May; 11(22):1738-40. PubMed ID: 6124947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study of efficacy and withdrawal.
    Fontaine R; Chouinard G; Annable L
    Psychopharmacol Bull; 1984; 20(1):126-7. PubMed ID: 6144130
    [No Abstract]   [Full Text] [Related]  

  • 39. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anxiety states and bromazepam (author's transl)].
    Ferreri M; Alby JM
    Nouv Presse Med; 1982 May; 11(22):1728-30. PubMed ID: 6124944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.